These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 40153

  • 1. Differential effects of typical and atypical neuroleptics on alpha-noradrenergic and dopaminergic post synaptic receptors.
    Le Fur G, Burgevin MC, Malgouris C, Uzan A.
    Neuropharmacology; 1979 Jul; 18(7):591-4. PubMed ID: 40153
    [No Abstract] [Full Text] [Related]

  • 2. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat.
    Wiesel FA, Sedvall G.
    Eur J Pharmacol; 1975 Feb; 30(2):364-7. PubMed ID: 236193
    [Abstract] [Full Text] [Related]

  • 3. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools.
    Robinson SE, Berney S, Mishra R, Sulser F.
    Psychopharmacology (Berl); 1979 Aug 08; 64(2):141-7. PubMed ID: 40288
    [No Abstract] [Full Text] [Related]

  • 4. Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function.
    Bartholini G.
    Adv Biochem Psychopharmacol; 1977 Aug 08; 16():607-11. PubMed ID: 18902
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and sigma receptors.
    Jaen JC, Caprathe BW, Pugsley TA, Wise LD, Akunne H.
    J Med Chem; 1993 Nov 26; 36(24):3929-36. PubMed ID: 7902870
    [Abstract] [Full Text] [Related]

  • 6. Effects of iminodibenzyl antipsychotic drugs on cerebral dopamine and alpha-adrenergic receptors.
    Setoguchi M, Sakamori M, Takehara S, Fukuda T.
    Eur J Pharmacol; 1985 Jun 19; 112(3):313-22. PubMed ID: 2862053
    [Abstract] [Full Text] [Related]

  • 7. Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.
    Greenberg DA, Snyder SH.
    Life Sci; 1977 Mar 15; 20(6):927-31. PubMed ID: 191710
    [No Abstract] [Full Text] [Related]

  • 8. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY, Zhang Y, Stockmeier CA.
    Eur J Pharmacol; 1992 May 27; 216(1):67-71. PubMed ID: 1388121
    [Abstract] [Full Text] [Related]

  • 9. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C, De Vries JB, Dijkstra D, Horn AS.
    Eur J Pharmacol; 1981 Apr 09; 70(4):541-50. PubMed ID: 6113149
    [Abstract] [Full Text] [Related]

  • 10. Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic properties.
    Uzan A, Le Fur G, Mitrani N, Kabouche M, Donadieu AM.
    Life Sci; 1978 Jul 17; 23(3):261-73. PubMed ID: 29181
    [No Abstract] [Full Text] [Related]

  • 11. The binding of fluorocatecholamines to adrenergic and dopaminergic receptors in rat brain membranes.
    Nimit Y, Cantacuzene D, Kirk KL, Creveling CR, Daly JW.
    Life Sci; 1980 Oct 27; 27(17):1577-85. PubMed ID: 6255279
    [No Abstract] [Full Text] [Related]

  • 12. The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
    Lew JY, Hata F, Ohashi T, Goldstein M.
    J Neural Transm; 1977 Oct 27; 41(2-3):109-21. PubMed ID: 21229
    [Abstract] [Full Text] [Related]

  • 13. Correlation between 3H-haloperidol binding in the striatum and brain amine metabolism in the rat after treatment with neuroleptics.
    Bürki HR.
    Life Sci; 1978 Aug 07; 23(5):437-41. PubMed ID: 29186
    [No Abstract] [Full Text] [Related]

  • 14. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC, Houwing HA, Horn AS.
    Eur J Pharmacol; 1982 Jun 16; 81(1):75-87. PubMed ID: 6126370
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain.
    Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH.
    Neuropharmacology; 1977 Sep 16; 16(9):549-56. PubMed ID: 21357
    [No Abstract] [Full Text] [Related]

  • 16. Multiple alpha 2-noradrenergic receptor sites in rat brain: selective regulation of high-affinity [3H]clonidine binding by guanine nucleotides and divalent cations.
    Rouot BM, U'Prichard DC, Snyder SH.
    J Neurochem; 1980 Feb 16; 34(2):374-84. PubMed ID: 6251166
    [No Abstract] [Full Text] [Related]

  • 17. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
    Scatton B, Bischoff S, Dedek J, Korf J.
    Eur J Pharmacol; 1977 Aug 15; 44(4):287-92. PubMed ID: 19266
    [Abstract] [Full Text] [Related]

  • 18. Proceedings: Do anti-psychotic drugs act by dopamine receptor blockade in the nucleus accumbens.
    Crow TJ, Deakin JF, Longden A.
    Br J Pharmacol; 1975 Oct 15; 55(2):295P-296P. PubMed ID: 120
    [No Abstract] [Full Text] [Related]

  • 19. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity.
    Saller CF, Salama AI.
    Neuropharmacology; 1985 Feb 15; 24(2):123-9. PubMed ID: 3990917
    [Abstract] [Full Text] [Related]

  • 20. The regulation of striatal DOPA synthesis by alpha 2-adrenoreceptors.
    Rabey JM, Passeltiner P, Bystritsky A, Engel J, Goldstein M.
    Brain Res; 1981 Dec 28; 230(1-2):422-6. PubMed ID: 6119140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.